Which has stronger valuation & earnings, HUM or CI?

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.38 $1.19B $10.57 38.67 Cigna Group $274.90B 0.27 $5.96B $24.17 11.61

Is HUM or CI more profitable?

Cigna Group has a net margin of 2.27% compared to Humana's net margin of 0.88%. Cigna Group's return on equity of 19.75% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.88% 11.20% 3.94% Cigna Group 2.27% 19.75% 5.34%

Does the media prefer HUM or CI?

In the previous week, Cigna Group had 7 more articles in the media than Humana. MarketBeat recorded 22 mentions for Cigna Group and 15 mentions for Humana. Humana's average media sentiment score of 1.11 beat Cigna Group's score of 0.94 indicating that Humana is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 9 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cigna Group 13 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, HUM or CNC?

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.38 $1.19B $10.57 38.67 Centene $194.78B 0.17 -$6.67B -$10.44 N/A

Is HUM or CNC more profitable?

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.88% 11.20% 3.94% Centene -2.51% 12.12% 3.20%

Does the media favor HUM or CNC?

In the previous week, Centene had 8 more articles in the media than Humana. MarketBeat recorded 23 mentions for Centene and 15 mentions for Humana. Humana's average media sentiment score of 1.11 beat Centene's score of 0.92 indicating that Humana is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 9 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Centene 12 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, HUM or ELV?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.38 $1.19B $10.57 38.67 Elevance Health $199.13B 0.46 $5.66B $22.50 18.60

Is HUM or ELV more profitable?

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.88%. Elevance Health's return on equity of 14.64% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.88% 11.20% 3.94% Elevance Health 2.47% 14.64% 5.22%

Does the media favor HUM or ELV?

In the previous week, Elevance Health had 12 more articles in the media than Humana. MarketBeat recorded 27 mentions for Elevance Health and 15 mentions for Humana. Elevance Health's average media sentiment score of 1.27 beat Humana's score of 1.11 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 9 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 20 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, HUM or MOH?

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.38 $1.19B $10.57 38.67 Molina Healthcare $45.43B 0.23 $472M -$0.18 N/A

Does the media refer more to HUM or MOH?

In the previous week, Humana had 6 more articles in the media than Molina Healthcare. MarketBeat recorded 15 mentions for Humana and 9 mentions for Molina Healthcare. Humana's average media sentiment score of 1.11 beat Molina Healthcare's score of 0.89 indicating that Humana is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 9 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Molina Healthcare 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, UNH or HUM?

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio UnitedHealth Group $447.57B 0.76 $12.06B $15.54 24.38 Humana $129.66B 0.38 $1.19B $10.57 38.67

Does the media refer more to UNH or HUM?

In the previous week, UnitedHealth Group had 29 more articles in the media than Humana. MarketBeat recorded 44 mentions for UnitedHealth Group and 15 mentions for Humana. Humana's average media sentiment score of 1.11 beat UnitedHealth Group's score of 0.97 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UnitedHealth Group 29 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive Humana 9 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Humana (HUM) Competitors

$408.78 +8.06 (+2.01%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$409.64 +0.85 (+0.21%)

As of 09/11/2026 07:33 PM Eastern

Compare

HUM vs. CI, CNC, ELV, MOH, and UNH

Should you buy Humana stock or one of its competitors? Humana's main competitors and comparable companies include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), and UnitedHealth Group (UNH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Humana compare to Cigna Group?

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

92.4% of Humana shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Humana has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

Humana presently has a consensus price target of $403.91, indicating a potential downside of 1.19%. Cigna Group has a consensus price target of $337.10, indicating a potential upside of 20.17%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts clearly believe Cigna Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43
Cigna Group	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

In the previous week, Cigna Group had 7 more articles in the media than Humana. MarketBeat recorded 22 mentions for Cigna Group and 15 mentions for Humana. Humana's average media sentiment score of 1.11 beat Cigna Group's score of 0.94 indicating that Humana is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	13 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group has a net margin of 2.27% compared to Humana's net margin of 0.88%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Cigna Group	2.27%	19.75%	5.34%

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.38	$1.19B	$10.57	38.67
Cigna Group	$274.90B	0.27	$5.96B	$24.17	11.61

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Humana pays out 33.5% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cigna Group beats Humana on 14 of the 19 factors compared between the two stocks.

How does Humana compare to Centene?

Humana (NYSE:HUM) and Centene (NYSE:CNC) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

92.4% of Humana shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Centene had 8 more articles in the media than Humana. MarketBeat recorded 23 mentions for Centene and 15 mentions for Humana. Humana's average media sentiment score of 1.11 beat Centene's score of 0.92 indicating that Humana is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	12 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Centene	-2.51%	12.12%	3.20%

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.38	$1.19B	$10.57	38.67
Centene	$194.78B	0.17	-$6.67B	-$10.44	N/A

Humana has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Centene has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

Humana currently has a consensus target price of $403.91, indicating a potential downside of 1.19%. Centene has a consensus target price of $70.05, indicating a potential upside of 5.45%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43
Centene	2 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.43

Summary

Humana beats Centene on 9 of the 17 factors compared between the two stocks.

How does Humana compare to Elevance Health?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.38	$1.19B	$10.57	38.67
Elevance Health	$199.13B	0.46	$5.66B	$22.50	18.60

Humana has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market.

In the previous week, Elevance Health had 12 more articles in the media than Humana. MarketBeat recorded 27 mentions for Elevance Health and 15 mentions for Humana. Elevance Health's average media sentiment score of 1.27 beat Humana's score of 1.11 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	20 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.4% of Humana shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.2% of Humana shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.88%. Elevance Health's return on equity of 14.64% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Elevance Health	2.47%	14.64%	5.22%

Humana currently has a consensus price target of $403.91, indicating a potential downside of 1.19%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 5.37%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. Humana pays out 33.5% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Elevance Health beats Humana on 16 of the 19 factors compared between the two stocks.

How does Humana compare to Molina Healthcare?

Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Humana has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

In the previous week, Humana had 6 more articles in the media than Molina Healthcare. MarketBeat recorded 15 mentions for Humana and 9 mentions for Molina Healthcare. Humana's average media sentiment score of 1.11 beat Molina Healthcare's score of 0.89 indicating that Humana is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana currently has a consensus target price of $403.91, indicating a potential downside of 1.19%. Molina Healthcare has a consensus target price of $202.44, indicating a potential downside of 0.83%. Given Molina Healthcare's higher probable upside, analysts plainly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43
Molina Healthcare	2 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.38	$1.19B	$10.57	38.67
Molina Healthcare	$45.43B	0.23	$472M	-$0.18	N/A

Humana has a net margin of 0.88% compared to Molina Healthcare's net margin of -0.02%. Humana's return on equity of 11.20% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.88%	11.20%	3.94%
Molina Healthcare	-0.02%	3.73%	0.97%

92.4% of Humana shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 1.4% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Humana beats Molina Healthcare on 12 of the 16 factors compared between the two stocks.

How does Humana compare to UnitedHealth Group?

UnitedHealth Group (NYSE:UNH) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.4%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. Humana pays out 33.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, UnitedHealth Group had 29 more articles in the media than Humana. MarketBeat recorded 44 mentions for UnitedHealth Group and 15 mentions for Humana. Humana's average media sentiment score of 1.11 beat UnitedHealth Group's score of 0.97 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UnitedHealth Group	29 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive
Humana	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

UnitedHealth Group currently has a consensus target price of $456.56, suggesting a potential upside of 20.52%. Humana has a consensus target price of $403.91, suggesting a potential downside of 1.19%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe UnitedHealth Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UnitedHealth Group	0 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43

UnitedHealth Group has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Humana has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.2% of UnitedHealth Group shares are owned by insiders. Comparatively, 0.2% of Humana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

UnitedHealth Group has a net margin of 3.14% compared to Humana's net margin of 0.88%. UnitedHealth Group's return on equity of 16.53% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UnitedHealth Group	3.14%	16.53%	5.43%
Humana	0.88%	11.20%	3.94%

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UnitedHealth Group	$447.57B	0.76	$12.06B	$15.54	24.38
Humana	$129.66B	0.38	$1.19B	$10.57	38.67

Summary

UnitedHealth Group beats Humana on 14 of the 20 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HUM vs. The Competition

Export

Metric	Humana	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$48.12B	$9.87B	$7.15B	$23.19B
Dividend Yield	0.88%	2.61%	2.56%	3.56%
P/E Ratio	38.67	33.27	272.98	28.69
Price / Sales	0.38	5.51	646.12	99.79
Price / Cash	16.65	125.76	77.04	33.82
Price / Book	2.77	5.29	10.33	4.74
Net Income	$1.19B	$313.25M	$3.49B	$1.07B
7 Day Performance	2.02%	-1.26%	-3.33%	-1.99%
1 Month Performance	5.12%	-0.98%	-0.42%	-2.68%
1 Year Performance	47.92%	15.13%	19.22%	10.45%

Humana Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HUM Humana	4.2229 of 5 stars	$408.79 +2.0%	$403.91 -1.2%	+46.5%	$48.12B	$129.66B	38.67	67,060	Positive News
CI Cigna Group	4.8118 of 5 stars	$276.22 -1.0%	$339.45 +22.9%	-8.3%	$72.99B	$274.90B	11.43	67,700	Ex-Dividend Analyst Forecast Insider Trade
CNC Centene	3.4369 of 5 stars	$64.32 -0.7%	$70.05 +8.9%	+94.5%	$31.77B	$202.94B	N/A	61,100	Analyst Forecast
ELV Elevance Health	4.2143 of 5 stars	$392.81 -0.4%	$440.90 +12.2%	+33.1%	$85.19B	$199.13B	17.46	97,100	Positive News
MOH Molina Healthcare	1.4168 of 5 stars	$198.43 -0.8%	$202.44 +2.0%	+8.3%	$10.36B	$44.52B	N/A	19,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HUM) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Summary

How does Humana compare to Centene?

Summary

How does Humana compare to Elevance Health?

Summary

How does Humana compare to Molina Healthcare?

Summary

How does Humana compare to UnitedHealth Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Do institutionals and insiders believe in HUM or CI?

Which has more volatility and risk, HUM or CI?

Do analysts prefer HUM or CI?

Does the media prefer HUM or CI?

Is HUM or CI more profitable?

Which has stronger valuation & earnings, HUM or CI?

Is HUM or CI a better dividend stock?

Summary

How does Humana compare to Centene?

Do insiders & institutionals hold more shares of HUM or CNC?

Does the media favor HUM or CNC?

Is HUM or CNC more profitable?

Which has stronger earnings and valuation, HUM or CNC?

Which has more risk and volatility, HUM or CNC?

Do analysts rate HUM or CNC?

Summary

How does Humana compare to Elevance Health?

Which has higher valuation and earnings, HUM or ELV?

Which has more volatility and risk, HUM or ELV?

Does the media favor HUM or ELV?

Do institutionals and insiders believe in HUM or ELV?

Is HUM or ELV more profitable?

Do analysts prefer HUM or ELV?

Is HUM or ELV a better dividend stock?

Summary

How does Humana compare to Molina Healthcare?

Which has more risk and volatility, HUM or MOH?

Does the media refer more to HUM or MOH?

Do analysts prefer HUM or MOH?

Which has preferable earnings & valuation, HUM or MOH?

Is HUM or MOH more profitable?

Do institutionals & insiders hold more shares of HUM or MOH?

Summary

How does Humana compare to UnitedHealth Group?

Is UNH or HUM a better dividend stock?

Does the media refer more to UNH or HUM?

Do analysts recommend UNH or HUM?

Which has more volatility and risk, UNH or HUM?

Do institutionals and insiders hold more shares of UNH or HUM?

Is UNH or HUM more profitable?

Which has preferable valuation & earnings, UNH or HUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools